Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 13.1711 | 99 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 13.1776 | 99 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 13.1586 | 99 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 12.9493 | 99 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 13.2954 | 99 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 13.2669 | 99 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 13.1741 | 99 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 13.206 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 13.1974 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 13.1966 | 99 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 13.1939 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 13.2178 | 99 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 13.1723 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 13.2556 | 99 |